Login Register Cart 0
Generic placeholder image

Combinatorial Chemistry & High Throughput Screening

Editor-in-Chief

ISSN (Print): 1386-2073
ISSN (Online): 1875-5402

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Clinical Trial

Clinical Trial Comparing Remimazolam with Propofol During Intravenous Anesthesia: A Prospective Randomised Clinical Trial

Author(s): Lu Yang, Jin Zhang, Nengke Xiao, Junjie Chen, Hengjuan Liu, Xuan He*, Xingpeng Xiao* and Fan Zhang*

Volume 27, Issue 10, 2024

Published on: 10 October, 2023

Page: [1544 - 1550] Pages: 7

DOI: 10.2174/0113862073247219230927050009

Price: $65

Abstract

Background and Objective: Remimazolam is a water-soluble sedative-anesthetic with short-acting properties and less hemodynamic effects. Currently, it is primarily used for gastroenteroscopy sedation.

Aim: The aim of this study is to investigate the effectiveness and safety of Remimazolam as an alternative intravenous anesthetic agent in surgical patients, in order to expand clinical options beyond Propofol.

Methods: Eighty patients aged 20-69 and classified as an American Society of Anesthesiologists physical status I-II were randomly assigned to either the Remimazolam group (RM group) or the Propofol group (PR group) for anesthesia induction and maintenance. Hemodynamics and Bispectral Index (BIS) were recorded before and after anesthesia, along with other relevant indices such as the time, to loss of consciousness (LoC), operation time, anesthesia time, awakening time, the number of cases of injection site pain. Additionally, the Ramsay sedation score, intraoperative awareness, dreaming, and postoperative adverse events were also assessed.

Results: After anesthesia, both groups experienced a significant decrease in blood pressure compared to baseline values, however, the reduction in blood pressure was less significant in the RM group than in the PR group (P<0.05). The heart rate of patients in the RM group remained relatively stable at all time points. There were significantly more cases of injection site pain and use of pressor or atropine during operation observed in the PR group compared to the RM group (P<0.05). There were no significant differences between the two groups in terms of time to loss of consciousness, anesthesia time, operation time, awakening time, and intraoperative awareness (P>0.05). However, at 5 and 30 minutes after awakening, the Ramsay sedation score was significantly better in the RM group compared to the PR group (P<0.05).

Conclusion: When remimazolam is used for intravenous anesthesia induction and maintenance, it can achieve a favorable anesthetic effect while maintaining a relatively stable blood pressure and heart rate. Patients experience shorter awakening times (8.3±3.7 min), better awakening quality (5 min Ramsay sedation score is 2 points), and no intraoperative awareness.

« Previous
Graphical Abstract

[1]
Birgenheier, N.M.; Stuart, A.R.; Egan, T.D. Soft drugs in anesthesia: remifentanil as prototype to modern anesthetic drug development. Curr. Opin. Anaesthesiol., 2020, 33(4), 499-505.
[http://dx.doi.org/10.1097/ACO.0000000000000879] [PMID: 32530892]
[2]
Sahinovic, M.M.; Struys, M.M.R.F.; Absalom, A.R. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin. Pharmacokinet., 2018, 57(12), 1539-1558.
[http://dx.doi.org/10.1007/s40262-018-0672-3] [PMID: 30019172]
[3]
Wesolowski, A.M.; Zaccagnino, M.P.; Malapero, R.J.; Kaye, A.D.; Urman, R.D. Remimazolam: Pharmacologic considerations and clinical role in anesthesiology. Pharmacotherapy, 2016, 36(9), 1021-1027.
[http://dx.doi.org/10.1002/phar.1806] [PMID: 27496519]
[4]
Schüttler, J.; Eisenried, A.; Lerch, M.; Fechner, J.; Jeleazcov, C.; Ihmsen, H. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers. Anesthesiology, 2020, 132(4), 636-651.
[http://dx.doi.org/10.1097/ALN.0000000000003103] [PMID: 31972655]
[5]
Cardia, L. Remimazolam: an ultrashort-acting intravenous anesthetic suitable for general anesthesia. Minerva Anestesiol., 2021, 87(10), 1059-1063.
[http://dx.doi.org/10.23736/S0375-9393.21.16006-7] [PMID: 34337928]
[6]
Xiao, X.; Xiao, N.; Zeng, F.; Chen, H.; Zhang, L.; He, X. Gastroscopy sedation: clinical trial comparing propofol and sufentanil with or without remimazolam. Minerva Anestesiol., 2022, 88(4), 223-229.
[http://dx.doi.org/10.23736/S0375-9393.21.15917-6] [PMID: 35072431]
[7]
Rex, D.K.; Bhandari, R.; Lorch, D.G.; Meyers, M.; Schippers, F.; Bernstein, D. Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial. Dig. Liver Dis., 2021, 53(1), 94-101.
[http://dx.doi.org/10.1016/j.dld.2020.10.039] [PMID: 33243567]
[8]
Doi, M.; Hirata, N.; Suzuki, T.; Morisaki, H.; Morimatsu, H.; Sakamoto, A. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J. Anesth., 2020, 34(4), 491-501.
[http://dx.doi.org/10.1007/s00540-020-02776-w] [PMID: 32303884]
[9]
Dai, G.; Pei, L.; Duan, F.; Liao, M.; Zhang, Y.; Zhu, M.; Zhao, Z.; Zhang, X. Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia. Minerva Anestesiol., 2021, 87(10), 1073-1079.
[http://dx.doi.org/10.23736/S0375-9393.21.15517-8] [PMID: 34263581]
[10]
Hemphill, S.; McMenamin, L.; Bellamy, M.C. Hopkins, PM Propofol infusion syndrome: a structured literature review and analysis of published case reports. Br. J. Anaesth., 2019, 122(4), 448-459.
[http://dx.doi.org/10.1016/j.bja.2018.12.025]
[11]
Adler, A.C. Propofol: Review of potential risks during administration. AANA J., 2017, 85(2), 104-107.
[PMID: 30501158]
[12]
Erdoes, G.; Basciani, R.M.; Eberle, B. Etomidate - a review of robust evidence for its use in various clinical scenarios. Acta Anaesthesiol. Scand., 2014, 58(4), 380-389.
[http://dx.doi.org/10.1111/aas.12289] [PMID: 24588359]
[13]
Ye, L.; Xiao, X.; Zhu, L. The comparison of etomidate and propofol anesthesia in patients undergoing gastrointestinal endoscopy: A systematic review and meta-analysis. Surg. Laparosc. Endosc. Percutan. Tech., 2017, 27(1), 1-7.
[http://dx.doi.org/10.1097/SLE.0000000000000373] [PMID: 28079763]
[14]
Valk, B.I. Struys, MMRF Etomidate and its Analogs: A Review of Pharmacokinetics and Pharmacodynamics. Clin. Pharmacokinet., 2021, 60(10), 1253-1269.
[http://dx.doi.org/10.1007/s40262-021-01038-6]
[15]
Morimoto, Y. Efficacy and safety profile of remimazolam for sedation in adults undergoing short surgical procedures. Ther. Clin. Risk Manag., 2022, 18(2), 95-100.
[http://dx.doi.org/10.2147/TCRM.S304556] [PMID: 35140469]
[16]
Kim, K.M. Remimazolam: Pharmacological characteristics and clinical applications in anesthesiology. Anesth. Pain Med., 2022, 17(1), 1-11.
[http://dx.doi.org/10.17085/apm.21115] [PMID: 35139608]
[17]
Shirozu, K.; Nobukuni, K.; Tsumura, S.; Imura, K.; Nakashima, K.; Takamori, S.; Higashi, M.; Yamaura, K. Neurological sedative indicators during general anesthesia with remimazolam. J. Anesth., 2022, 36(2), 194-200.
[http://dx.doi.org/10.1007/s00540-021-03030-7] [PMID: 34999964]
[18]
Veselis, R.A.; Reinsel, R.A.; Feshchenko, V.A. Wroński, M. The comparative amnestic effects of midazolam, propofol, thiopental, and fentanyl at equisedative concentrations. Anesthesiology, 1997, 87(4), 749-764.
[http://dx.doi.org/10.1097/00000542-199710000-00007] [PMID: 9357875]
[19]
Bulach, R.; Myles, P.S.; Russnak, M. Double-blind randomized controlled trial to determine extent of amnesia with midazolam given immediately before general anaesthesia. Br. J. Anaesth., 2005, 94(3), 300-305.
[http://dx.doi.org/10.1093/bja/aei040] [PMID: 15567810]
[20]
Heavner, M.S.; Gorman, E.F.; Linn, D.D.; Yeung, S.Y.A.; Miano, T.A. Systematic review and meta-analysis of the correlation between bispectral index (BIS) and clinical sedation scales: Toward defining the role of BIS in critically ill patients. Pharmacotherapy, 2022, 42(8), 667-676.
[http://dx.doi.org/10.1002/phar.2712] [PMID: 35707961]
[21]
Olotu, C. Postoperative neurocognitive disorders. Curr. Opin. Anaesthesiol., 2020, 33(1), 101-108.
[http://dx.doi.org/10.1097/ACO.0000000000000812] [PMID: 31764008]
[22]
Tan, Y.; Ouyang, W.; Tang, Y.; Fang, N.; Fang, C.; Quan, C. Effect of remimazolam tosilate on early cognitive function in elderly patients undergoing upper gastrointestinal endoscopy. J. Gastroenterol. Hepatol., 2022, 37(3), 576-583.
[http://dx.doi.org/10.1111/jgh.15761] [PMID: 34907594]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy